Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal microbiota transplantation to improve vedolizumab outcomes in Crohn's disease
MOH_2018-05-27_002313Phase 2Not yet recruiting
- Sponsor
- ד"ר ניצן מהרשק
- Start
- May 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Crohn's disease comparing FMT before vedolizumab with Placebo before vedolizumab (2 arms). Planned start May 2018; status: not yet recruiting.
02
Drugs
vedolizumaballogeneic fecal microbiota
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on MOH_2018-05-27_002313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-05-27_002313.